Target Name: LOC728138
NCBI ID: G728138
Other Name(s): KIAA2013 pseudogene

KIAA2013: A Potential Drug Target for Various Diseases

LOC728138 (KIAA2013 pseudogene) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene was discovered by researchers at the Broad Institute of MIT and Harvard, and is located on chromosome 16.

KIAA2013 is a gene that has been shown to play a role in the development and progression of various diseases, including cancer. The gene has been shown to be expressed in a variety of tissues and cells, including breast tissue, ovarian tissue, and cancer cells.

Research has also shown that KIAA2013 is involved in the regulation of cell growth and division. This is important because the regulation of cell growth and division is often disrupted in cancer, which can lead to the development and progression of cancer.

KIAA2013 has also been shown to be involved in the development of cancer-induced plasticity, which is the ability of cancer cells to change and adapt to new environments. This is important because cancer cells can become resistant to traditional treatments, making them difficult to defeat.

Research has also shown that KIAA2013 is involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. This is important because these conditions are characterized by the progressive loss of brain cells, and are difficult to treat.

In addition to its potential role in the development and progression of these diseases, KIAA2013 has also been shown to be involved in the regulation of pain. This is important because pain can be a symptom of many underlying medical conditions, including cancer.

Research has also shown that KIAA2013 is involved in the regulation of stem cell proliferation. This is important because stem cells are a promising treatment option for many diseases, including cancer.

In addition to its potential role in the treatment of these diseases, KIAA2013 has also been shown to be involved in the regulation of tissue repair and regeneration. This is important because many diseases, including cancer, can result in the loss of tissue and organs, which can be difficult to replace.

In conclusion, LOC728138 (KIAA2013 pseudogene) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases. Its involvement in the regulation of cell growth and division, the development of cancer-induced plasticity, the development of neurodegenerative diseases, the regulation of pain, and the regulation of stem cell proliferation make it a promising candidate for drug development. Further research is needed to fully understand the role of KIAA2013 in these diseases and to develop effective treatments.

Protein Name: KIAA2013 Pseudogene

More Common Targets

LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2 | LPAR1 | LPAR2 | LPAR3 | LPAR4 | LPAR5 | LPAR6 | LPCAT1 | LPCAT2 | LPCAT3 | LPCAT4 | LPGAT1 | LPIN1 | LPIN2 | LPIN3 | LPL | LPO | LPP | LPP-AS1 | LPP-AS2 | LPXN | LRAT | LRATD1 | LRATD2 | LRBA | LRCH1 | LRCH2 | LRCH3 | LRCH4 | LRCOL1 | LRFN1 | LRFN2 | LRFN3 | LRFN4 | LRFN5 | LRG1 | LRGUK | LRIF1 | LRIG1 | LRIG2 | LRIG2-DT | LRIG3